Three-year-old Ollie Chu, born with the rare and life-limiting Hunter syndrome, is showing improvement after receiving an ...
Smithsonian Magazine on MSN
This Toddler Was the First Person to Receive a Test Treatment for a Rare Genetic Disorder. Nine Months Later, His Progress Is Inspiring Hope
Oliver Chu is one of five kids participating in a clinical trial investigating a gene therapy for Hunter syndrome, a disorder with symptoms akin to childhood dementia that limits life expectancy ...
The parents of a three-year-old boy born with a devastating, life-limiting genetic condition say they are now excited for his ...
A three year-old boy with a rare life-limiting condition has undergone a groundbreaking new treatment developed in Manchester ...
Ollie Chu travelled from California in the United States to the UK earlier this year to undergo the gene therapy treatment. | ...
Ollie Chu travelled from California in the United States to the UK earlier this year to undergo the gene therapy treatment. | ...
The parents of a three-year-old boy born with a devastating, life-limiting genetic condition say they are now excited for his ...
Interesting Engineering on MSN
3-year-old boy gets world-first gene therapy to treat life-threatening disorder
A three-year-old Oliver (Ollie) Chu has become the world’s first patient to receive a revolutionary stem cell gene therapy for Hunter syndrome.
The parents of a three-year-old boy born with a devastating genetic condition say they are now excited for his future after ...
A child with Hunter Syndrome has amazed doctors with his progress after becoming the first person in the world to receive a ...
Denali Therapeutics and Royalty Pharma entered a $275 million royalty funding agreement based on future sales of tividenofusp alfa.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback